The Earth’s magnetic field is a fundamental physical force that serves as the primary means of navigation for many biological species. Although migratory birds or marine inhabitants naturally use the planet’s weak magnetic impulses for orientation, the human body is inert toward this force. In medicine, the perception and use of magnetic fields are traditionally associated with high-tech, complex, and expensive visualization systems (MRI). However, the latest breakthrough achieved in bioengineering may fundamentally change the existing approach.
A publication in the journal Nature describes an innovative methodology. The research concerns the creation of artificially modified proteins capable of perceiving low-intensity magnetic fields. With this technology, the diagnosis of pathologies and the management of pharmacological agents within the body will be possible remotely, through non-invasive methods.
How Does the Magnetic “Switch” Work?
The functional transformation of modified proteins is based on the ability to convert magnetic impulses into biochemical or optical signals. Under the influence of a magnetic field, the proteins change their fluorescence intensity or their ability to bind with target molecules (affinity).
This process takes place at the quantum level, specifically through the radical pair mechanism: during photoexcitation, electrons move within the protein, creating a transitional state. An external magnetic field influences the spin state of the electrons, which determines their subsequent reaction. As a result, the emission of photons decreases, representing a reliable diagnostic indicator for clinical monitoring.
The practical significance of the technology encompasses several strategic directions. First and foremost, magneto-sensitive proteins will make the creation of low-power MRI systems and the cellular visualization of pathologies possible.
Simultaneously, this breakthrough lays the foundation for the remote management of pharmacotherapy. This method implies the activation of medication exclusively within the area of targeted magnetic influence. For example, during anti-tumor therapy, the action of the drug is localized exclusively within the damaged focus. This will reduce systemic side effects to a minimum and protect healthy tissues from toxic influence.
Although the technology is currently at the preclinical research stage, the scientific community sees within it the potential for a radical transformation of the biomedical field. The integration of remotely controlled proteins into practical medicine will significantly increase diagnostic accuracy and therapeutic safety. This technology will make treatment procedures less invasive and more effective for the patient.
Source: Science
